Befejeződött1. fázis
Characterization of Immune Response in Participants from a Posdinemab Study
Key facts
- Where
- Bordeaux és Lille Cedex, FranciaországSee the 2 sites
- Phase
- 1. fázis
Where in Franciaország
- Pellegrin HospitalBordeaux, FranciaországNo longer taking part
- Centre Hospitalier Universitaire De LilleLille Cedex, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Janssen Cilag International
- Trial code
- EU 2024-514634-20-00
- Record updated
- 2025. május 23.